
Shree Ganesh Remedies Ltd Shows Technical Momentum Shift Amid Mixed Market Signals
2026-05-21 08:04:07Shree Ganesh Remedies Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish outlook. Despite a slight dip in the stock price on 21 May 2026, the evolving technical indicators suggest a nuanced market sentiment for this micro-cap pharmaceutical player, warranting close attention from investors and analysts alike.
Read More
Golden Cross Forms in Shree Ganesh Remedies Ltd — On a Day the Stock Fell 0.66%. What the Mixed Signals Mean
2026-05-20 18:00:37The 50-day moving average has crossed above the 200-day moving average for Shree Ganesh Remedies Ltd, signalling a golden cross on 20 May 2026. Yet, the stock declined 0.66% on the same day, while monthly momentum indicators remain bearish. This juxtaposition of signals invites a closer examination of the technical and fundamental context behind the crossover.
Read MoreWhen is the next results date for Shree Ganesh Remedies Ltd?
2026-05-12 23:17:33The next results date for Shree Ganesh Remedies Ltd is scheduled for 14 May 2026....
Read More
Shree Ganesh Remedies Ltd is Rated Strong Sell
2026-04-23 10:11:04Shree Ganesh Remedies Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 12 January 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 23 April 2026, providing investors with the latest comprehensive analysis.
Read More
Shree Ganesh Remedies Ltd is Rated Strong Sell
2026-04-12 10:10:33Shree Ganesh Remedies Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 12 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Shree Ganesh Remedies Ltd Valuation Shifts Signal Elevated Price Risk
2026-04-06 08:01:30Shree Ganesh Remedies Ltd has seen a notable shift in its valuation parameters, moving from a fair to an expensive rating, driven primarily by its elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios. This change contrasts with its historical valuation and peer group metrics, raising questions about the stock's price attractiveness in the Pharmaceuticals & Biotechnology sector.
Read More
Shree Ganesh Remedies Ltd is Rated Strong Sell
2026-04-01 10:10:44Shree Ganesh Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 01 April 2026, providing investors with the latest insights into its performance and outlook.
Read More
Shree Ganesh Remedies Ltd Faces Bearish Momentum Amid Technical Downgrade
2026-03-30 08:02:47Shree Ganesh Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a marked shift in technical momentum, with key indicators signalling a bearish trend. The stock’s recent price action and technical parameters suggest increasing downside pressure, raising concerns for investors amid a challenging market backdrop.
Read More
Shree Ganesh Remedies Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-03-24 08:02:00Shree Ganesh Remedies Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade amid a challenging market backdrop. Despite a recent downgrade to a Strong Sell rating, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a recalibration of investor expectations, warranting a closer examination of its price attractiveness relative to peers and historical benchmarks.
Read MoreCompliances-Reg.24(A)-Annual Secretarial Compliance
25-May-2026 | Source : BSEAnnual Secretarial Compliance Report for the year ended March 31 2026
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
20-May-2026 | Source : BSETranscript of Earnings Call
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
16-May-2026 | Source : BSEAudio Recording - Earnings Call held on May 15 2026
Corporate Actions
No Upcoming Board Meetings
Shree Ganesh Remedies Ltd has declared 5% dividend, ex-date: 07 Sep 23
No Splits history available
Shree Ganesh Remedies Ltd has announced 1:5 bonus issue, ex-date: 01 Nov 21
Shree Ganesh Remedies Ltd has announced 7:100 rights issue, ex-date: 03 Feb 23